Article
Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.
Pharmacogenetics and genomics - 1 Sept 2015
Wanga Valentine, Venuto Charles, Morse Gene D, Acosta Edward P, Daar Eric S, Haas David W, Li Chun, Shepherd Bryan E
Abstract excerpt
BACKGROUND: Tenofovir disoproxil fumarate (TDF) causes kidney toxicity in some patients. We carried out genomewide analyses to identify associations with plasma tenofovir clearance and change in creatinine clearance (CrCl) during the first 6 months after initiating therapy among patients randomized to TDF/emtricitabine-containing regimens in AIDS Clinical Trials Group protocol A5202. METHODS: Pharmacokinetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
